2026.05.19

Launch of the public offering of Genomtec shares to raise funds for the finalization of the M&A process and the commercialization of Genomtec ID and OncoSNAAT® technologies

Genontec S.A. announced the launch of a public offering of shares by its principal shareholder, 5HT Family Foundation, through an accelerated ...
2026.03.19

Genomtec plans to issue shares. The proceeds will be used to support the M&A process and commercialize projects. The company has concluded an investment agreement with a key shareholder.

Genomtec S.A. on April 13, 2026, at which the Shareholders will vote on an increase in the Company’s share capital through the issue of up to 2 ...
2026.02.12

Genomtec lines up technology trials with potential Asian partners during M&A efforts

Genomtec S.A. started key preparatory activities related to planned testing of Genomtec diagnostic devices in Asia. These activities are directly ...
2025.07.31

Genomtec’s Supervisory Board appointed Leroy Huntley to the Company’s Management Board

Genomtec S.A. announced the appointment of Mr. Leroy Huntley to the Company’s Management Board on July 30, 2025, with effect from August 1, ...
2025.07.14

Genomtec has the consent of its shareholders to make a contribution of assets to its subsidiaries in order to accelerate the project sale process

At the Extraordinary General Meeting of Genomtec SA on July 11, 2025, the Shareholders adopted resolutions on the contribution in kind of ...
2025.03.26

Genomtec implements changes in organizational structure to accelerate M&A process

Genomtec SA has established two special purpose vehicles, GMT ID SA and GMT Genomics SA, in which it holds 100% of the shares. They will receive ...